A European clinician consensus report has revealed that Clostridium difficile infection (CDI) is twice as common than MRSA infections in hospitals.
Approximately EUR€3bn was spent per annum on the disease across Europe, according to the report.
The report was prepared based on the views of 1,000 healthcare professionals across Europe, and was presented at the Healthcare Infection Society (HIS) International Congress in Lyon, France.
A consortium including European experts prepared a series of 29 statements, representing their collective views on the diagnosis and management of CDI in Europe.
Questionnaires were completed by 1,047 clinicians involved in managing CDI from Germany, France, Spain, Italy, Sweden and the UK.
Recommendations were suggested to further develop CDI services, based on the consensus scores of the 1,047 respondent clinicians.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The recommendations include implementation of clearly defined algorithms for stool specimen selection, collection, testing and better definitions of how optimal CDI treatment can be planned for patients with co-morbidities.
In addition, the recommendations comprise increased collaboration of hospitals and community-based health and social care services to improve CDI management.
Guy’s and St Thomas’ NHS Foundation Trust Dr Simon Goldenberg said: "Patients who suffer from CDI tend to be those who are already extremely vulnerable, such as cancer patients, people who have received immunosuppressants or antibiotics, and those who had recent surgery."
"This survey is important because it identifies the views of healthcare professionals who are actively involved in the day-to-day testing, diagnosis and treatment of CDI and who are responsible for reducing transmission and recurrence rates."